Jul 30
Jul 30
Jul 29
Jul 22
Jul 19
Jul 17

Peri-implant mucositis is the most common biological complication of dental implant therapy, affecting a substantial proportion of patients within the first decade of function. Although it is reversible when caught early, untreated mucositis can progress to peri-implantitis and ev...
Peri-implant mucositis is the most common biological complication of dental implant therapy, affecting a substantial proportion of patients within the first decade of function. Although it is reversible when caught early, untreated mucositis can progress to peri-implantitis and eventual implant loss, making early recognition and systematic management essential.
Peri-implant mucositis is an inflammatory lesion confined to the soft tissues surrounding a dental implant, with no evidence of bone loss beyond the initial crestal remodeling that follows implant placement. It is the implant analogue of gingivitis around natural teeth, and it represents the earliest, reversible stage of peri-implant disease.
The condition is defined clinically by bleeding on gentle probing, erythema, and sometimes swelling of the peri-implant mucosa. Unlike peri-implantitis, mucositis does not show progressive radiographic bone loss, and it resolves when the inflammatory stimulus is removed.
Epidemiological data consistently show that peri-implant mucositis is far more prevalent than peri-implantitis. A widely cited systematic review by Derks and Tomasi (2015), which pooled data from multiple European cohorts, estimated that peri-implant mucositis affects roughly 43 percent of implant patients at the patient level, while peri-implantitis affects around 22 percent.
More recent analyses have reported even higher figures. A 2019 systematic review and meta-analysis by Lee and colleagues found a patient-level prevalence of peri-implant mucositis of approximately 46.8 percent, underscoring that nearly half of all implant patients will experience this condition at some point. These numbers make mucositis a routine clinical reality rather than a rare complication.
Several factors increase the likelihood of developing peri-implant mucositis, and many are modifiable.
Inadequate plaque control is the single most important risk factor. The peri-implant mucosa has a weaker biological seal than the dentogingival junction, and plaque accumulation around the abutment rapidly triggers an inflammatory response. Patients who do not maintain effective daily cleaning around their implants are at substantially higher risk.
Smoking impairs local blood flow and immune function, and it has been consistently associated with higher rates of peri-implant mucositis and peri-implantitis. A systematic review by Renvert and Persson (2009) identified smoking as one of the strongest predictors of peri-implant disease progression.
Patients with a history of periodontitis carry a significantly elevated risk. The same microbial and host-response factors that drive periodontal destruction predispose these patients to peri-implant inflammation, and they require more intensive maintenance protocols.
Restorations that are difficult to clean, with overcontoured margins or inaccessible embrasure spaces, promote plaque retention and increase mucositis risk. Design for cleanability should be a priority from the prosthetic planning stage.
The diagnosis of peri-implant mucositis is based on clinical examination. Key findings include:
- Bleeding on gentle probing (BOP) at one or more sites
- Erythema and edema of the peri-implant mucosa
- No radiographic evidence of progressive bone loss
- Probing depths that may be increased but without suppuration or bone loss
A single episode of bleeding on probing is sufficient to diagnose mucositis in the absence of bone loss. Probing around implants should be performed with a light force, typically 0.25 N, to avoid damaging the peri-implant seal.
Because mucositis is reversible, management focuses on removing the inflammatory stimulus and re-establishing a healthy peri-implant environment.
Professional therapy begins with a careful assessment of the implant, the prosthesis, and the patient's home care. Mechanical debridement of the implant surface is performed with instruments that will not damage the titanium surface, such as plastic, carbon-fiber, or titanium-tipped scalers. Ultrasonic scalers with specialized implant tips can also be used.
For sites with persistent inflammation, adjunctive antimicrobial therapy may be considered. Chlorhexidine mouthwash, applied for a limited period, can help control the bacterial load, and local delivery of chlorhexidine gel or minocycline has shown benefit in some studies.
Long-term success depends on the patient's ability to maintain the implant. Patients should be instructed in the use of interdental brushes, which are more effective than floss for cleaning around implant abutments, and in the correct technique for brushing the implant area. Regular recall visits, typically every three to six months for high-risk patients, allow early detection and treatment of recurrent inflammation.
Prevention of peri-implant mucositis begins before the implant is placed. Patients with active periodontal disease should complete periodontal therapy and achieve stable periodontal health before implant surgery. Smoking cessation should be strongly encouraged, and prosthetic designs should prioritize access for cleaning.
After placement, a structured maintenance program is essential. The recall interval should be individualized based on the patient's risk profile, with high-risk patients seen more frequently. At each maintenance visit, the clinician should assess plaque levels, bleeding on probing, and probing depths, and reinforce home care instructions.
Modern oral care technology can support patients in maintaining the demanding hygiene routines that implants require. Smart toothbrushes with pressure sensors and coverage tracking, such as those offered by BrushO, help patients clean systematically and avoid the over-brushing that can damage peri-implant soft tissues. Real-time feedback on brushing coverage is particularly valuable for implant patients, who must clean specific areas around abutments and prostheses with consistent technique.
Peri-implant mucositis is a common, reversible inflammatory condition that affects nearly half of all implant patients. Early diagnosis through regular probing and bleeding assessment, combined with professional debridement and effective patient home care, can prevent progression to peri-implantitis and implant loss. For patients with implants, a structured maintenance program is not optional; it is the foundation of long-term implant success.
Aug 19
Aug 17
Jul 30
Jul 30
Jul 29
Jul 22
Jul 19
Jul 17

The removal of supra- and subgingival biofilm is the foundation of periodontal therapy, and the ultrasonic scaler has become the instrument of choice for much of this work. A mechanical tip vibrating at high frequency, energized by an oscillating water spray, disrupts the biofilm, chips away the ...

Teledentistry uses telecommunication technology to provide dental care at a distance, allowing the clinician to assess a patient, triage an emergency, plan a case, or monitor a course of treatment without a physical visit. The idea is not new, but the pandemic of 2020 accelerated its adoption and...

A white spot lesion is the earliest clinically visible stage of caries, a subsurface demineralization that still can be reversed if the environment of the mouth is changed. Remineralization restores mineral into the damaged enamel and is the treatment of choice before a lesion reaches the cavitat...

Photobiomodulation, once called low-level laser therapy, uses red or near-infrared light at doses that do not heat the tissue to modulate cellular activity and promote healing. In dentistry the therapy has moved from a curiosity to a documented adjunct for pain, inflammation, and wound recovery, ...

Repair of a periodontal defect closes the pocket but leaves a long junctional epithelium as a fragile scar, while true regeneration restores the cementum, periodontal ligament, and bone that the disease destroyed. Enamel matrix derivative, marketed as Emdogain, is a purified extract of developing...

Conventional implant site preparation removes bone with cutting drills that sacrifice the very tissue the implant relies on for stability. Osseodensification, introduced by Huwais and Meyer in 2017, reverses this logic by using a specially designed bur that compacts and densifies the bone walls o...

An implant overdenture is a removable prosthesis retained by two or more implants, and it converts the unstable conventional denture into a chewing platform that the patient trusts. Between the implant and the denture sits the attachment, the small mechanical or magnetic connector that holds the ...

The removal of biofilm is the oldest task in dentistry, yet conventional polishing with a rubber cup and paste still scrubs the surface, leaves the deep pockets untouched, and often produces a spray of aerosolized bacteria. Guided biofilm therapy changes this by first staining the biofilm so that...

Conventional caries excavation removes soft dentin with rotary burs and hand instruments, but it also removes sound tissue and often leaves the patient anxious and the clinician pressing with unnecessary force. Chemomechanical caries removal offers a gentler path: a chemical agent softens the inf...

Bell's palsy is an acute, usually unilateral paralysis of the facial nerve that is not caused by an identifiable tumor, trauma, or infection, and it presents to the dental team as a sudden inability to close the eye, smile, or raise the eyebrow on one side. Because the paralysis affects structure...